Home sequential compression devices market seen reaching $1.62 billion by 2030

The home sequential compression devices market is projected to grow from $1.17 billion in 2025 to $1.26 billion in 2026, then reach $1.62 billion by 2030, according to The Business Research Company. Rising obesity, more home healthcare, and demand for non-invasive circulation therapies are driving adoption.

Why it matters: - Home sequential compression devices give patients a non-invasive way to manage lymphedema, venous insufficiency, and other circulation problems at home. - The market’s growth signals more demand for home-based chronic care as patients, providers, and insurers shift treatment outside clinical settings. - Rising obesity rates add to the need for circulation-support products that can be used without repeated clinic visits.

What happened: - The Business Research Company released its Home Sequential Compression Devices Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Aug. 11, 2026. - The report pegs the global home sequential compression devices market at $1.17 billion in 2025 and $1.26 billion in 2026. - The report forecasts the market will reach $1.62 billion by 2030. - North America held the largest market share in 2025.

The details: - The 2025-to-2026 growth rate is 7.6%. - The 2026-to-2030 growth rate is forecast at 6.5%. - Growth is tied to higher lymphedema and venous disorder prevalence, broader home healthcare access, stronger preference for non-invasive therapies, pneumatic compression advances, and better insurance coverage for at-home treatment. - The report expects demand to rise for connected medical devices, remote patient monitoring, personalized compression therapies, and wearable medical technology. - The report highlights portable and wearable compression devices, rechargeable and battery-powered products, and improved remote monitoring features as major trends. - Home sequential compression devices use pneumatic technology to deliver intermittent pressure to limbs. - The devices aim to improve blood circulation, support venous return, and reduce swelling. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. - The report includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, and updated graphics and tables. - A free sample is available here. - The full report is available here.

Between the lines: - Obesity is one of the clearest demand drivers because higher body weight can reduce mobility and raise venous thromboembolism risk. - The UK’s Office for Health Improvement & Disparities reported in May 2025 that 64.5% of adults in England were overweight or obese in 2023-24, up from 64.0% a year earlier. - The market’s focus on portability, battery power, and remote monitoring suggests buyers want therapy that fits everyday routines, not just prescribed clinical use.

What's next: - The strongest growth is likely to come from devices that combine compression therapy with connected features and easier home use. - Expansion in home-based chronic disease management should keep pushing demand through 2030. - Continued product innovation in wearable and rechargeable devices is likely to shape competitive positioning.

The bottom line: - Home sequential compression devices are moving from niche therapy tools toward a broader home-care category, with obesity, chronic disease management, and remote care trends supporting long-term growth.